Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COBLL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NPFF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
SPTB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMRT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAST4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PGLYRP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP1GDS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC39 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM127 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERICH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAPN15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM26F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on